pancreatic cancer semaglutide GLP-1s appear to cut risk. Researchers are asking why and how : NPR GLP-1 Side Effects and Semaglutide:

CEO Brian Niccol explained to Axios in June that the new innovation is geared toward a number of consumer groups, such as 20-year-old males, 50-year-old females and people taking GLP-1s

You will be monitored during treatment

Clinical trials have not established a direct causal relationship between these medications and nocturnal hyperhidrosis

For patients who have not responded fully to semaglutide or tirzepatide, retatrutide may represent a meaningful step forward

The pharmacovigilance data revealed a significantly elevated incidence of adverse reactions in the metformin monotherapy cohort compared to the combination therapy group